Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05074524 · ClinicalTrials.gov registry record · NA

Repetitive Transcranial Magnetic Stimulation to Reduce Heroin Cravings

A NA study of Opioid Use Disorder and Transcranial Magnetic Stimulation, sponsored by University of Nevada, Las Vegas.

Completed
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT05074524 is a NA study of Opioid Use Disorder and Transcranial Magnetic Stimulation that has completed, run by University of Nevada, Las Vegas. The registered enrollment target is 24 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05074524, a NA study of Opioid Use Disorder and Transcranial Magnetic Stimulation, has completed, sponsored by University of Nevada, Las Vegas.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to test the effect of repetitive transcranial magnetic stimulation (rTMS) on opioid cravings among adult patients with Opioid Use Disorder.

Interventions

  • DEVICE Repetitive Transcranial Magnetic Stimulation
  • DEVICE Sham Repetitive Transcranial Magnetic Stimulation

Study Locations (1)

Nevada

  • University of Nevada, Las Vegas - Las Vegas

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2021-10-06
Est. Completion 2022-01-24
Phase NA

Sponsor

University of Nevada, Las Vegas

52 total trials

What the Registry Record Tells You About NCT05074524

The ClinicalTrials.gov registry entry for NCT05074524 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower). The listed sponsor is University of Nevada, Las Vegas, which has 52 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Repetitive Transcranial Magnetic Stimulation is the first listed.

NCT05074524 reports 1 study location spanning 1 distinct geographic area - top geographies include Nevada.

Frequently Asked Questions

What is clinical trial NCT05074524 about?

NCT05074524 is a clinical study titled "Repetitive Transcranial Magnetic Stimulation to Reduce Heroin Cravings". The purpose of this research study is to test the effect of repetitive transcranial magnetic stimulation (rTMS) on opioid cravings among adult patients with Opioid Use Disorder.

What is the current status of trial NCT05074524?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2021-10-06. Estimated completion is 2022-01-24.

What conditions does trial NCT05074524 study?

This clinical trial studies the following conditions: Opioid Use Disorder, Transcranial Magnetic Stimulation, Craving, Heroin Abuse.

What interventions are being tested in trial NCT05074524?

The interventions under investigation include: Repetitive Transcranial Magnetic Stimulation (DEVICE), Sham Repetitive Transcranial Magnetic Stimulation (DEVICE).

Who is sponsoring clinical trial NCT05074524?

This trial is sponsored by University of Nevada, Las Vegas, which has 52 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05074524 being conducted?

This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.